Nanobody Leadership ChromoTek pioneered alpaca Nanobodies and is a market leader for Nanobody-based reagents, with custom Nanobody services for the pharmaceutical industry. Sales opportunities include targeting pharma and biotech programs needing bespoke Nanobodies and imaging reagents, with potential for cross-selling within Proteintech's ecosystem.

Global Expansion With offices in Martinsried, Germany and Hauppauge, NY and a lean team, there is room to accelerate growth via regional distributors, CRO partnerships, and co-development deals in the EU and US. A focused partner strategy can widen reach to academic labs, biotech startups, and pharma.

Digital Pathology Synergy Proteintech initiatives around digital-ready pathology workflows and 3D Epitope Mapping open joint opportunities to align ChromoTek Nanobodies with advanced imaging and epitope mapping solutions. Consider bundled offerings that couple Nanobodies with validated data and AI-enabled tools for pathology customers.

Tech Driven Selling ChromoTek's technology stack, including Salesforce and Typeform, indicates readiness for data-driven sales. Leverage these capabilities to build ICP-driven campaigns and accelerate procurement decisions among pharma, contract labs, and research institutions.

Growth Funding Readiness The business operates in a sub-$1M revenue band with modest funding. This position is attractive for strategic partnerships or co-investment to scale manufacturing and broaden product lines, especially through cross-sales with Proteintech and joint go-to-market initiatives.